v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 24, 2024
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:        
Net loss $ (862,791) $ (654,640) $ (6,278,191) $ (1,517,431)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 150,000 300,000  
Impairment loss on Intellectual property 2,550,000  
Loss on investment 500,000  
Amortization of debt discounts 6,667  
Stock based compensation 400,000 1,238,650  
Gain on debt settlement 175,000  
Changes in operating assets and liabilities:        
Inventory, net 882  
Accounts receivable 354  
Prepaid expenses and other current assets 8,627 (43,775) (79,985)  
Accounts payable 1,379 139,502 (95,101)  
Accrued expenses and other current liabilities 30,537 6,816 (10,180)  
Net cash used in operating activities (272,248) (551,743) (1,692,258)  
Cash flows from investing activities:        
Cash acquired in reverse merger 608,596  
Net cash provided by investing activities 608,596  
Cash flows from financing activities:        
Proceeds from initial public offering 3,235,692  
Proceeds from Convertible notes 170,000  
Proceeds from related party debt 666,232 120,000  
Repayments of related party debt (120,000)  
Proceeds from sale of stock 6,800  
Net cash provided by financing activities 666,232 3,412,492  
Net change in cash and cash equivalents 336,348 114,489 1,720,234  
Cash and cash equivalents, beginning of period 132,650 18,161 468,998 18,161
Cash and cash equivalents, end of period 468,998 132,650 2,189,232 $ 468,998
Non-cash investing and financing activities:        
Shares sold on subscription 800  
Settlement of related party debt 78,980  
Discounts on convertible promissory notes $ 118,017